I-Lumen Scientific announced on 31 March 2026 tha
Author: Michael
I-Lumen Scientific announced on 31 March 2026 tha
After pulling in $1 billion across two private r
New US licensing deal brings chronic kidney dise
Allocetra moves into Phase 2b as Enlivex targets
Anavex Life Sciences withdrew its application for
Insilico Medicine announced a drug discovery coll
Allergan Aesthetics, an AbbVie company, presented
Aubrey De Grey breaks down longevity escape velo
Longevity biotech investment in 2026 is no longe